Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?

BACKGROUND/AIM: Despite the well-established benefits of cardiac resynchronization therapy (CRT) in heart failure (HF) patients with left ventricular ejection fraction (LVEF) ≤35%, many patients with less reduced EF remain refractory to optimized medical treatment and at high risk of morbidity and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawfik Ghanem, Mazen, Allam, Lamyaa Elsayed, Samir Ahmed, Rania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796628/
https://www.ncbi.nlm.nih.gov/pubmed/31543195
http://dx.doi.org/10.1016/j.ihj.2019.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796628/
https://www.ncbi.nlm.nih.gov/pubmed/31543195
http://dx.doi.org/10.1016/j.ihj.2019.04.010

Ejemplares similares